Boutique Venture Partners focuses on emerging healthcare and life science solutions to make a significant impact at scale. We leverage our deep connections within the healthcare ecosystem to get early access to innovations and discoveries coming out of premiere academic institutes and industry. We pay particular attention to early-stage companies that are :
Developing novel approaches/platforms with solid IP
Founded by authentic entrepreneurs with deep domain expertise
Have large growth potential while demonstrating societal impact.
At Boutique, our team of top-tier scientists and business leaders work closely with portfolio companies to launch the next generation of transformative technologies.
At Boutique, we invest in Early Detection and Early Treatment, including precision health and precision medicine. We are a disease-agnostic fund targeting Cancer, Neurological, Metabolic, Infectious, Orphan, and Cardiovascular diseases.
Smart devices: Smartlens
In vitro diagnostics
AI enabled approaches
Med. Professional development
Immersive learning (e.g. VR/AR)